How much funding does Fight CRC & CGA-IGC Early Career Award provide?

Fight CRC & CGA-IGC Early Career Award provides Not specified in funding.

When is the deadline for Fight CRC & CGA-IGC Early Career Award?

This grant has a rolling deadline or the deadline has not been announced.

Fight CRC & CGA-IGC Early Career Award

FIGHT COLORECTAL CANCER INC

Foundation Annual Grants for Cancer Nonprofits Grants for Science Research

Apply Now

Funding Amount

Not specified

Deadline

Rolling / Open

Grant Type

foundation

Overview

Fight CRC & CGA-IGC Early Career Award

Overview: A collaborative research grant awarded jointly by Fight Colorectal Cancer and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) to advance patient care and support for individuals and families affected by hereditary cancer syndromes.

Award Type: Research grant to early-career investigators

Geographic Scope: United States and Americas region

Focus Areas:

Hereditary cancer syndromes

Familial colorectal cancer

Early-onset colorectal cancer (EAO CRC)

Inherited colorectal cancer syndromes

Patient-centered research

Advancement of science and clinical care

Patient advocacy

Eligibility:

Early-career investigators

Researchers focused on hereditary, familial, and early-onset colorectal cancer

Scientists with research projects addressing gaps in care for high-risk populations

What They Fund:

Research focused on improving clinical outcomes for patients with hereditary cancer syndromes

Biomarker development and detection methods

Quality improvement and informatics research

Electronic health record interventions

Non-invasive screening and detection methods

Studies addressing care gaps for advanced colorectal polyps and familial risk

Recent Award Recipients:

2023: Dr. Alessandro Mannucci, Beckman Research Institute - developing novel blood test for early-onset CRC detection

2022: Timothy Yen, Loma Linda University Faculty Medical Group - electronic health record intervention for familial CRC risk communication

Background Context:

Approximately 5-10% of CRC cases have hereditary component

Up to 25% of all CRC cases attributed to high familial risk

1 in 3 people have family history of colorectal cancer

By 2030, CRC poised to be leading cause of cancer deaths in individuals under 50

Partnership Mission: Enhance well-being of patients and families by ensuring cutting-edge research and clinical care paradigms inform patient support tools and policy change in equitable and inclusive manner.